Columbia Wanger Asset Management’s West Pharmaceutical WST Stock Holding History

Columbia Wanger Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$24.2M	Hold	244,984	–	–	0.36%	122
2017 Q3	$23.6M	Sell	244,984 -236,563	-49%	-$21.4M	0.35%	117
2017 Q2	$45.5M	Sell	481,547 -98,669	-17%	-$9.08M	0.65%	55
2017 Q1	$47.4M	Sell	580,216 -26,767	-4%	-$2.24M	0.66%	51
2016 Q4	$51.5M	Sell	606,983 -174,454	-22%	-$13.7M	0.72%	39
2016 Q3	$58.2M	Sell	781,437 -142,935	-15%	-$11.3M	0.76%	35
2016 Q2	$70.1M	Buy	924,372 +607,208	+191%	+$44.2M	0.81%	30
2016 Q1	$22M	Buy	+317,164	New	+$19.1M	0.24%	132

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Columbia Wanger Asset Management's WST Position: Q4 2017 in Review

Columbia Wanger Asset Management held its West Pharmaceutical (WST) position steady in Q4 2017 at 244,984 shares worth $24.2M. The position accounts for 0.36% of the portfolio, ranked #122.

Columbia Wanger Asset Management first reported a position in WST in Q1 2016 and has held it in 8 quarters since. The position peaked at $70.1M in Q2 2016. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

Columbia Wanger Asset Management held 244,984 shares of West Pharmaceutical worth $24.2M as of Q4 2017.
Columbia Wanger Asset Management left its West Pharmaceutical share count unchanged in Q4 2017.
West Pharmaceutical made up 0.36% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #122 holding.
Columbia Wanger Asset Management first reported a position in West Pharmaceutical in Q1 2016 and has held it in 8 quarters since.
Columbia Wanger Asset Management's West Pharmaceutical position peaked at $70.1M in Q2 2016.
338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.